| The 10th Kitasato University-Harvard School of Public Health Symposium Advanced and Global Drug Development Techniques: Innovative Strategies for Future Objectives | ||
| Preface | Takeuchi M，Wei LJ | iii |
| Faculty Members | vi-xvii | |
| Program | xviii-xxiii | |
| Opening | ||
| Opening Remarks | Aizawa Y | 3-4 |
| Congratulatory Remarks | Narita M | 5-7 |
| Welcome Address | Zelen M | 9-16 |
| Keynote Session | Chairperson：Imura H | 17-46 |
| Promoting Development of the Life Sciences in Japan: Researcher View Points | Kayama T | 19-31 |
| Advancement of Life Science in Japan: Industry View Points | Shoda T | 33-46 |
| Session 1 Promoting & Projecting New Drug Development Techniques | Chairperson：Takeuchi M | 47-94 |
| Undertaking the Role of Pharmaceutical Drug Development in Japan | Iwasaki M | 49-56 |
| Japanese Policy for Innovative Drug Development | Miyata T | 57-70 |
| The Role and Contribution of Academia | Narukawa M | 71-6 |
| International Activities of PMDA Encouraging New Pharmaceuticals Development in Asia | Tsukano M | 77-84 |
| Panel Discussion | 85-94 | |
| Session 2 Brainstorming Techniques of Early Stage Drug Development: From FIM to POC | Chairperson：Murakami M | 95-141 |
| Early Phase Clinical Development in Japan: Lilly Strategy | Yoshikawa A | 97-104 |
| The Strategies and Methods of Early Stage Drug Development -What can and should Japan do?- | Sawada T | 105-14 |
| The Strategies and Methods of Early Stage Drug Development: Bioventure | Nii T | 115-22 |
| The Strategies and Methods of Early Stage Drug Development: Academia | Nagamura F | 123-32 |
| Panel Discussion | 133-41 | |
| Session 3 Application of New Drug Development Tools | Chairperson：Toyoshima S | 143-86 |
| Pharmacometrics in US: Yesterday, Today & Tomorrow | Wagg JK | 145-55 |
| Regulatory Perspective for an Application of New Drug Development Tools | Uyama Y | 157-64 |
| Application of Modeling & Simulations in Oncology Drug Development | Guo F | 165-74 |
| Personalized Medicine: Biostatistical Methodology of the Future | Takeuchi M | 175-9 |
| Panel Discussion | 181-6 | |
| Session 4 Medicine-The Next Step | Chairperson：Hiyama Y | 187-230 |
| Vaccine Innovation: Challenges and Opportunities to Protect Health | Gerberding J | 189-98 |
| Vaccines in Japan | Nakayama T | 199-209 |
| The Role of the European Institutions in the Public Health in Europe: The Case of Immunization Programs | Martin JJP | 211-7 |
| Health Policy Based Upon Evidence and Value | Mori R | 219-26 |
| Panel Discussion | 227-30 | |
| Conclusion & Closing Remarks | ||
| Conclusion | Zelen M | 233-4 |
| Closing Remarks | Takeuchi M | 235-7 |